The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells

1-methyl-D-tryptophan (1-D-MT) is currently being used in clinical trials in patients with relapsed or refractory solid tumors with the aim of inhibiting indoleamine-2,3-dioxygenase (IDO)-mediated tumor immune escape. IDO is expressed in tumors and tumor-draining lymph nodes and degrades tryptophan...

Descripción completa

Detalles Bibliográficos
Autores principales: Opitz, Christiane A., Litzenburger, Ulrike M., Opitz, Uta, Sahm, Felix, Ochs, Katharina, Lutz, Christian, Wick, Wolfgang, Platten, Michael
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098827/
https://www.ncbi.nlm.nih.gov/pubmed/21625531
http://dx.doi.org/10.1371/journal.pone.0019823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098827/
https://www.ncbi.nlm.nih.gov/pubmed/21625531
http://dx.doi.org/10.1371/journal.pone.0019823

Ejemplares similares